Fulgent Genetics, Inc. Quarterly Cost of Revenue in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Fulgent Genetics, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2015 to Q3 2024.
  • Fulgent Genetics, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $45M, a 0.29% increase year-over-year.
  • Fulgent Genetics, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $177M, a 8.77% decline year-over-year.
  • Fulgent Genetics, Inc. annual Cost of Revenue for 2023 was $185M, a 26.7% decline from 2022.
  • Fulgent Genetics, Inc. annual Cost of Revenue for 2022 was $252M, a 17% increase from 2021.
  • Fulgent Genetics, Inc. annual Cost of Revenue for 2021 was $216M, a 140% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $177M $45M +$129K +0.29% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $177M $44.5M -$2.74M -5.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $180M $42.4M -$4.98M -10.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $185M $45.3M -$9.44M -17.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $194M $44.8M -$14.7M -24.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $209M $47.3M -$12.8M -21.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 $222M $47.4M -$30.4M -39.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $252M $54.7M -$7.42M -11.9% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-28
Q3 2022 $259M $59.6M +$16.1M +37% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $243M $60.1M +$24.2M +67.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $219M $77.7M +$3.65M +4.93% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $216M $62.1M +$10.4M +20% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $205M $43.5M +$17.2M +65.5% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-28
Q2 2021 $188M $35.9M +$28.1M +365% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-28
Q1 2021 $160M $74.1M +$70M +1726% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-28
Q4 2020 $89.8M $51.8M +$48.1M +1325% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 $41.7M $26.3M +$22.4M +576% Jul 1, 2020 Sep 30, 2020 10-K 2022-02-28
Q2 2020 $19.3M $7.72M +$4.1M +113% Apr 1, 2020 Jun 30, 2020 10-K 2022-02-28
Q1 2020 $15.2M $4.06M +$1.09M +36.7% Jan 1, 2020 Mar 31, 2020 10-K 2022-02-28
Q4 2019 $14.1M $3.63M +$865K +31.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-08
Q3 2019 $13.2M $3.89M +$1.27M +48.7% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-08
Q2 2019 $12M $3.62M +$1.08M +42.3% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-08
Q1 2019 $10.9M $2.97M +$196K +7.07% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-08
Q4 2018 $10.7M $2.77M +$224K +8.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 $10.5M $2.61M +$344K +15.2% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-13
Q2 2018 $10.1M $2.54M +$665K +35.4% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-13
Q1 2018 $9.46M $2.77M +$913K +49.1% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-13
Q4 2017 $8.55M $2.55M +$682K +36.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-22
Q3 2017 $7.87M $2.27M +$125K +5.83% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-22
Q2 2017 $7.74M $1.88M +$468K +33.2% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-22
Q1 2017 $7.28M $1.86M +$555K +42.6% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-22
Q4 2016 $6.72M $1.86M -$863K -31.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-20
Q3 2016 $7.58M $2.14M +$1.23M +133% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-20
Q2 2016 $6.36M $1.41M +$639K +82.8% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-20
Q1 2016 $5.72M $1.3M +$651K +99.7% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-20
Q4 2015 $5.07M $2.73M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-17
Q3 2015 $918K Jul 1, 2015 Sep 30, 2015 10-K 2017-03-17
Q2 2015 $772K Apr 1, 2015 Jun 30, 2015 10-K 2017-03-17
Q1 2015 $653K Jan 1, 2015 Mar 31, 2015 10-K 2017-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.